Welcome to our dedicated page for Boston Walden Trust Small Cap Fund news (Ticker: BOSOX), a resource for investors and traders seeking the latest updates and insights on Boston Walden Trust Small Cap Fund stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Boston Walden Trust Small Cap Fund's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Boston Walden Trust Small Cap Fund's position in the market.
On March 1, 2023, Boston Trust Walden Small Cap Fund (BOSOX) announced that it will be closed to new investors effective May 1, 2023. This decision means that only existing shareholders and qualified defined contribution retirement plans can purchase shares of the Fund after this date. Although sales of Fund shares may reopen in the future, potential investors must refer to the Fund's prospectus for detailed information regarding investment objectives and risks. Mutual fund investing carries risks, including the potential loss of principal.
